Jorveza (budesonide orodispersible tablets) / Dr Falk  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jorveza (budesonide orodispersible tablets) / Dr Falk
2020-002593-27: Budesonide as a treatment for inflammation in stomach complaints. Budesonide als behandeling voor ontstekingsreacties bij maagklachten.

Not yet recruiting
4
36
Europe
Budesonide, Capsule, Jorveza
UZ Leuven, KU Leuven
Functional dyspepsia Functionele dyspepsie, Chronic stomach disease Chronische maagklachten, Diseases [C] - Digestive System Diseases [C06]
 
 

Download Options